Fondée en 2019, QUMEA réunit une équipe interdisciplinaire unique en son genre et un produit incomparable, leader du secteur.
L’enthousiasme pour la technologie et l’engagement à la mettre au service de la santé sont notre moteur commun.
Cyrill Gyger
Chief Executive Officer
David Meier
Chief Operating Officer
Jonas Reber
Chief Technology Officer
Anna Windisch
Chief Marketing Officer
Christoph Barmet
Chief Product Officer
Valerio Signorelli
Chief Commercial Officer
Chantal Marty
Chief Financial Officer
Micha Kämpfer
VP Nordics
Ido Gershoni
Director Application Excellence
Fabio De Nardis
Lead Customer Success
Daniel Hadorn
Lead Engineer Devices
Adrian Pauli
Lead Engineer Software
Julie Grandeau
Commercial Excellence Manager
Philip Vandermeulen
Senior Software Engineer
Tobias Gatschet
Embedded Engineer
Bojana Marjanovic
Backoffice Manager
Stephan Raible
Senior Research Engineer
Philipp Rebsamen
Senior Research Engineer
Marco Schaub
Senior Software Engineer
Wagner Lima
Software Engineer
Martin Bunc
Technical Project Engineer
Elisa Stauffer
Intern Medical Informatics
Deborah Leuenberger
Customer Success Manager
Dominik Hutter
Account Director
Marco Buri
Research Engineer
Marcel Schevemann
VP Germany
Sokol Balaj
Customer Success & Product Manager
Federica Pitirra
Quality & Regulatory Affairs Manager
Annie Stor
Customer Success Manager
Karine Zehnder
Customer Success Manager
Mario Kaufmann
Senior Software Engineer
Livia Holm
Account Director
Silvana Lamparska
Customer Success Manager
Raphael Joost
Research Engineer
Tanja Rölli
Director Marketing & Communications
Emil Alibegic
Technical Project Engineer
Disclosure
Responsible for the content:
QUMEA AG
Westbahnhofstrasse 3
CH-4500 Solothurn
+41 (0)32 525 60 50
info@qumea.com
UID: CHE-439.197.016
Legal form: Public Limited Company
Contact Person:
Cyrill Gyger
Please also see QUMEA's Privacy Policy.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Images used under license from kandis-fotografie.ch, QUMEA AG, Shutterstock.com.
Regulatory Statement & Conformity
MDR Statement
QUMEA Care is not a medical device according to Regulation (EU) 2017/745 and therefore does not fall within its scope of the same.
QUMEA Care is intended for the prevention of injuries. According to Article 2 paragraph 1 of Regulation (EU) 2017/745 (European Union Medical Device Regulation - MDR), the prevention of an injury is not a medical purpose. The movement and activity data as recorded and displayed by QUMEA Care are ultimately intended to be used to prevent injuries. The device is not intended to be used for "diagnosis, monitoring, treatment, alleviation of, or compensation for, an injury" and accordingly, not for a specific medical purpose.
QUMEA Mobility Sense is a Class 1 medical device according to Regulations (EU) 2017/745 (European Union Medical Device Regulation - MDR) and MepV (2020/812.213).
QUMEA Mobility Sense is intended to be used for prevention of Decubitus ulcers and pressure areas (ICD L89). The product is solely used to inform the caretaker when a patient did not show a certain level of mobilization for a specific amount of time. The required level of mobilization is defined as a change in posture of the recumbent subject (e.g. turning from supine to lateral position). No diagnostic or therapeutic decisions can be made based on the output of the data.
Conformity (CE)
QUMEA sensor products are in conformity with European health, safety, and environmental protection standards.
QUMEA AG CHRN: CHRN-MF-20002870
Classification and conformity documentation, as well as additional documents, are available upon request from QUMEA AG.
Demo anfordern
Wir freuen uns sehr, dass Sie QUMEA in Aktion sehen wollen. Bitte hinterlassen Sie uns ein paar Angaben und wir werden uns umgehend mit Ihnen in Verbindung setzen, um eine Demo mit Ihnen zu vereinbaren.